Internal medicine, Endocrinology, Inflammation, C-reactive protein and Biochemistry are his primary areas of study. His Internal medicine research incorporates themes from Immunology and alpha-Tocopherol. The study incorporates disciplines such as Proinflammatory cytokine and Monocyte in addition to Endocrinology.
His Inflammation research integrates issues from Blood vessel, Receptor, Endothelium and Cytokine. His C-reactive protein research incorporates elements of Thromboxane, Bystander effect, Culprit and Thromboxane B2. Ishwarlal Jialal has researched Antioxidant in several fields, including Oxidative stress and Lipoprotein.
His primary areas of investigation include Internal medicine, Endocrinology, Diabetes mellitus, Inflammation and Metabolic syndrome. His Internal medicine study is mostly concerned with C-reactive protein, Cholesterol, Lipoprotein, Oxidative stress and TLR4. His Endocrinology research includes themes of Proinflammatory cytokine, Receptor, Antioxidant and Monocyte.
In general Antioxidant, his work in Tocopherol and Vitamin E is often linked to Ascorbic acid linking many areas of study. The various areas that Ishwarlal Jialal examines in his Inflammation study include Endothelium, Cytokine and Endothelial dysfunction. His Metabolic syndrome study incorporates themes from Leptin, Chemerin, Adipokine, Adiponectin and Adipose tissue.
Ishwarlal Jialal mainly focuses on Internal medicine, Metabolic syndrome, Diabetes mellitus, Endocrinology and Residency training. Ishwarlal Jialal performs integrative Internal medicine and Value research in his work. His work carried out in the field of Metabolic syndrome brings together such families of science as Chemerin, Adipokine, Inflammation, Adiponectin and Adipose tissue.
His research on Inflammation concerns the broader Immunology. His Endocrinology research is multidisciplinary, relying on both Proinflammatory cytokine and Biomarker. His Residency training study integrates concerns from other disciplines, such as Continuing medical education, Physiology and Biochemistry.
Ishwarlal Jialal focuses on Metabolic syndrome, Internal medicine, Diabetes mellitus, Endocrinology and Inflammation. Ishwarlal Jialal combines subjects such as Biomarker, Adiponectin, Metabolic pathway, Adipose tissue and Adipokine with his study of Metabolic syndrome. His research in Internal medicine is mostly concerned with Amyloidosis.
His Diabetes mellitus study incorporates themes from Insulin, Pathogenesis, Bioinformatics and Lipoprotein. His work in the fields of Endocrinology, such as Insulin resistance, intersects with other areas such as Cachexia. His study in Inflammation is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha and Platelet, Platelet lymphocyte ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Demonstration That C-Reactive Protein Decreases eNOS Expression and Bioactivity in Human Aortic Endothelial Cells
Senthil Kumar Venugopal;Sridevi Devaraj;Ivan Yuhanna;Philip Shaul.
Circulation (2002)
Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels
I. Jialal;D. Stein;D. Balis;S. M. Grundy.
Circulation (2001)
C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells Implications for the Metabolic Syndrome and Atherothrombosis
Sridevi Devaraj;Dan Yan Xu;Ishwarlal Jialal.
Circulation (2003)
C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
Ishwarlal Jialal;Sridevi Devaraj;Senthil K. Venugopal.
Hypertension (2004)
Oxidative stress and atherosclerosis.
Uma Singh;Ishwarlal Jialal.
Pathophysiology (2006)
VITAMIN E, OXIDATIVE STRESS, AND INFLAMMATION
U. Singh;S. Devaraj;I. Jialal.
Annual Review of Nutrition (2005)
Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
Mohan R. Dasu;Sridevi Devaraj;Samuel Park;Ishwarlal Jialal.
Diabetes Care (2010)
High glucose induces Toll-like receptor expression in human monocytes: Mechanism of activation
Mohan R. Dasu;Sridevi Devaraj;Ling Zhao;Daniel H. Hwang.
Diabetes (2008)
The Effect of α-Tocopherol Supplementation on LDL Oxidation: A Dose-Response Study
Ishwarlal Jialal;Ishwarlal Jialal;Cindy J. Fuller;Beverley A. Huet.
Arteriosclerosis, Thrombosis, and Vascular Biology (1995)
Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State
Sridevi Devaraj;Mohan R. Dasu;Jason Rockwood;William Winter.
The Journal of Clinical Endocrinology and Metabolism (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Baylor College of Medicine
The University of Texas Southwestern Medical Center
Oregon State University
University of Southern California
University of Toronto
University of California, Davis
Scripps Research Institute
University of California, Davis
Tufts University
Harvard University
University of South Florida
University of Zurich
ETH Zurich
University of Jinan
Georgia Institute of Technology
Murdoch University
University of Aberdeen
University of Puerto Rico
Massey University
National Academies of Sciences, Engineering, and Medicine
University of Tokyo
University of Montreal
University of the Witwatersrand
Education University of Hong Kong
Memorial Sloan Kettering Cancer Center
Perimeter Institute